ALL:NYSEAllstate Corporation (The) analysis
Data as of Oct 14, 2026 - not real-time
- Latest price
- $236.17
- Risk: medium
- 4/10Medium risk
Summary
The Allstate Corporation trades at $236.17, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has lost 8.4%. With RSI at 49.9 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $219.51 up to resistance at $254.83.
On valuation the read is undervalued — earnings multiple of 4.7 versus a 15.5 sector average, below the peer group. The average analyst target implies 14.0% above today's level. Revenue is growing at 11.8% on a 19.0% profit margin. The 1.83% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 25.8%, a beta of -0.42 and a maximum drawdown of 19.4%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
The horizons line up on buy — conviction 9 out of 10.
On valuation the read is undervalued — earnings multiple of 4.7 versus a 15.5 sector average, below the peer group. The average analyst target implies 14.0% above today's level. Revenue is growing at 11.8% on a 19.0% profit margin. The 1.83% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 25.8%, a beta of -0.42 and a maximum drawdown of 19.4%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
The horizons line up on buy — conviction 9 out of 10.
Top market events
- The Allstate Corporation NYSE:ALL is one of the largest personal property and casualty insurers in the U.
- Allstate Corp stock closed at USD 242.86 on September 21, 2026, down 2.79 percent. Second-quarter ad
- Second-quarter revenue hit USD 18.60 billion, up 11.80 percent year over year. Allstate stock costs
Market outlook
Short term
< 1 yearPositive
Model confidence7/107 out of 10
Key factors
- Trading above the 200-day average of 225.61
- MACD momentum is positive
- 30-day price change of -8.4%
Medium term
1–3 yearsPositive
Model confidence7/107 out of 10
Key factors
- P/E of 4.7 versus sector average of 15.5
- Trading above the 200-day average of 225.61
- Analyst targets imply +14.0% versus the current price
Long term
> 3 yearsPositive
Model confidence9/109 out of 10
Key factors
- P/E of 4.7 versus sector average of 15.5
- Analyst targets imply +14.0% versus the current price
- Profit margin of 19.0% is healthy
Key metrics
Financial health
Revenue Growth11.80%
Profit Margin18.97%
P/E Ratio4.7
ROE46.11%
ROA8.68%
Debt/Equity22.26
P/B Ratio1.9
Op. Cash Flow$12.5B
Free Cash Flow$15.2B
Industry P/E15.5
Technical analysis
TrendNeutral
RSI49.9
Support$219.51
Resistance$254.83
MA 20$230.80
MA 50$247.97
MA 200$225.61
MACDBullish
VolumeDecreasing
Fear & Greed Index91.3
Valuation
Fair Value$1,162.09
Target Price$269.27
Upside/Downside14.02%
GradeUndervalued
TypeBlend
Dividend Yield1.83%
Risk assessment
Beta-0.42
Volatility25.83%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.